» Articles » PMID: 27601870

Clinical Presentation and Visual Status of Retinitis Pigmentosa Patients: a Multicenter Study in Southwestern Nigeria

Overview
Journal Clin Ophthalmol
Publisher Dove Medical Press
Specialty Ophthalmology
Date 2016 Sep 8
PMID 27601870
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: To review the visual status and clinical presentation of patients with retinitis pigmentosa (RP).

Methodology: Multicenter, retrospective, and analytical review was conducted of the visual status and clinical characteristics of patients with RP at first presentation from January 2007 to December 2011. Main outcome measure was the World Health Organization's visual status classification in relation to sex and age at presentation. Data analysis by SPSS (version 15) and statistical significance was assumed at P<0.05.

Results: One hundred and ninety-two eyes of 96 patients with mean age of 39.08±18.5 years and mode of 25 years constituted the study population; 55 (57.3%) were males and 41 (42.7%) females. Loss of vision 67 (69.8%) and night blindness 56 (58.3%) were the leading symptoms. Twenty-one (21.9%) patients had a positive family history, with RP present in their siblings 15 (71.4%), grandparents 11 (52.3%), and parents 4 (19.4%). Forty (41.7%) were blind at presentation and 23 (24%) were visually impaired. Blindness in six (15%) patients was secondary to glaucoma. Retinal vascular narrowing and retinal pigmentary changes of varying severity were present in all patients. Thirty-five (36.5%) had maculopathy, 36 (37.5%) refractive error, 19 (20%) lenticular opacities, and eleven (11.5%) had glaucoma. RP was typical in 85 patients (88.5%). Older patients had higher rates of blindness at presentation (P=0.005); blindness and visual impairment rate at presentation were higher in males than females (P=0.029).

Conclusion: Clinical presentation with advanced diseases, higher blindness rate in older patients, sex-related difference in blindness/visual impairment rates, as well as high glaucoma blindness in RP patients requires urgent attention in southwestern Nigeria.

Citing Articles

Clinical presentation and macular morphology in retinitis pigmentosa patients.

Okonkwo O, Hassan A, Agweye C, Victor U, Akanbi T Ann Afr Med. 2024; 22(4):451-455.

PMID: 38358145 PMC: 10775947. DOI: 10.4103/aam.aam_181_22.


Retinitis Pigmentosa in Onitsha, Nigeria.

Nwosu S, Ndulue C, Ndulue O, Uba-Obiano C J West Afr Coll Surg. 2022; 10(2):30-35.

PMID: 35558569 PMC: 9089809. DOI: 10.4103/jwas.jwas_65_21.


Ocular abnormalities in a large patient cohort with retinitis pigmentosa in Western China.

Tan L, Long Y, Li Z, Ying X, Ren J, Sun C BMC Ophthalmol. 2021; 21(1):43.

PMID: 33461530 PMC: 7812647. DOI: 10.1186/s12886-020-01797-z.


Profile, Visual Presentation and Burden of Retinal Diseases Seen in Ophthalmic Clinics in Sub-Saharan Africa.

Nkanga D, Adenuga O, Okonkwo O, Ovienria W, Ibanga A, Agweye C Clin Ophthalmol. 2020; 14:679-687.

PMID: 32189962 PMC: 7067142. DOI: 10.2147/OPTH.S226494.


Acute angle closure following periorbital botulinum toxin injection in a patient with retinitis pigmentosa.

Tsai J Taiwan J Ophthalmol. 2017; 7(2):104-107.

PMID: 29018766 PMC: 5602147. DOI: 10.4103/tjo.tjo_41_17.

References
1.
Mancil R, Mancil G, King E, Legault C, Munday J, Alfieri S . Improving nighttime mobility in persons with night blindness caused by retinitis pigmentosa: A comparison of two low-vision mobility devices. J Rehabil Res Dev. 2005; 42(4):471-86. DOI: 10.1682/jrrd.2004.08.0091. View

2.
Marmor M . Visual loss in retinitis pigmentosa. Am J Ophthalmol. 1980; 89(5):692-8. DOI: 10.1016/0002-9394(80)90289-5. View

3.
Buch H, Vinding T, La Cour M, Appleyard M, Jensen G, Nielsen N . Prevalence and causes of visual impairment and blindness among 9980 Scandinavian adults: the Copenhagen City Eye Study. Ophthalmology. 2004; 111(1):53-61. DOI: 10.1016/j.ophtha.2003.05.010. View

4.
Onakpoya O, Adeoye A, Akinsola F, Adegbehingbe B . Prevalence of blindness and visual impairment in Atakunmosa West Local Government area of southwestern Nigeria. Tanzan Health Res Bull. 2007; 9(2):126-31. DOI: 10.4314/thrb.v9i2.14315. View

5.
Parmeggiani F . Clinics, epidemiology and genetics of retinitis pigmentosa. Curr Genomics. 2011; 12(4):236-7. PMC: 3131730. DOI: 10.2174/138920211795860080. View